If the RECOVER-TLC team declines to include leronl
Post# of 151513
(Total Views: 498)
Posted On: 03/26/2025 12:07:55 AM
Quote:
If the RECOVER-TLC team declines to include leronlimab, we will resume the pursuit of a pilot study in patients with ME/CFS, for which we already have a draft protocol synopsis and lead investigator identified.
Due to recent idiotic events, NIH funding for numerous new trials is up in the air.
(8)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼